Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07XWB
|
|||
| Former ID |
DNC013065
|
|||
| Drug Name |
4-(thiazol-2-yl)phenyl butylcarbamate
|
|||
| Synonyms |
CHEMBL376748; 4-(thiazol-2-yl)phenyl butylcarbamate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H16N2O2S
|
|||
| Canonical SMILES |
CCCCNC(=O)OC1=CC=C(C=C1)C2=NC=CS2
|
|||
| InChI |
1S/C14H16N2O2S/c1-2-3-8-16-14(17)18-12-6-4-11(5-7-12)13-15-9-10-19-13/h4-7,9-10H,2-3,8H2,1H3,(H,16,17)
|
|||
| InChIKey |
HIQUBTZOYOZSPC-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system. J Med Chem. 2006 Jul 27;49(15):4650-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.